The standard diagnostic tools for GC follow-up after treatment are upper endoscopy, computed tomography, and the tumor markers (carcinoembryonic antigen (CEA), cancer antigen 19-9 (CA 19-9), and carbohydrate antigen 72-4 (CA 72-4)) [8]. Here, CEACAM5 is linked to gastric cancer.